This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115: 755–764.
Damle RN, Batliwalla FM, Ghiotto F, Valetto A, Albesiano E, Sison C et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004; 103: 375–382.
Roos G, Krober A, Grabowski P, Kienle D, Buhler A, Dohner H et al. Short telomeres are associated with genetic complexity, high risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 2008; 111: 2246–2252.
Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M et al. Telomere length is an independent predictor of survival, treatment requirement and Richter′s syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009; 23: 1062–1072.
Lin TT, Letsolo BT, Jones RE, Rowson J, Pratt G, Hewamana S et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukaemia: evidence for a telomere crisis. Blood 2010; 116: 1899–1907.
Brugat T, Nguyen-Khac F, Grelier A, Merle-Beral H, Delic J . Telomere dysfunction-induced foci arise with the onset of telomeric deletions and complex chromosomal aberrations in resistant chronic lymphocytic leukemia cells. Blood 2010; 116: 239–249.
Sabourin M, Zakian VA . ATM-like kinases and regulation of telomerase: lessons from yeast and mammals. Trends Cell Biol 2008; 18: 337–346.
Austen B, Skowronska A, Baker C, Powell JE, Gardiner A, Oscier D et al. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol 2007; 25: 5448–5457.
Acknowledgements
This work was supported by Cancer Research UK (C17199/A5603), Leukaemia & Lymphoma Research (no. 8044) and the Wales Office of Research and Development (TRP08-038).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
BBC carried out the experimental work and analysis; TTL, GA, VW and REJ contributed to the experimental work; CF and DGO provided clinical samples and edited the manuscript; TS jointly conceived the study and edited the manuscript; CP jointly supervised the study and edited the manuscript; DMB jointly conceived and supervised the study, analysed the data and wrote the manuscript.
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Britt-Compton, B., Lin, T., Ahmed, G. et al. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage. Leukemia 26, 826–830 (2012). https://doi.org/10.1038/leu.2011.281
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.281